147 related articles for article (PubMed ID: 19439165)
21. Induction of specific-locus and dominant lethal mutations in male mice in the low dose range by methyl methanesulfonate (MMS).
Ehling UH; Neuhäuser-Klaus A
Mutat Res; 1990 May; 230(1):61-70. PubMed ID: 2342498
[TBL] [Abstract][Full Text] [Related]
22. DNA alkylation studies of combined treatment with methylnitrosourea and ethylmethanesulfonate in mice.
Platzek T; Bochert G
Teratog Carcinog Mutagen; 2000; 20(1):27-34. PubMed ID: 10607375
[TBL] [Abstract][Full Text] [Related]
23. Dominant lethal studies with alkylating agents: dose-response relationships.
Arnold DW; Kennedy GL; keplinger ML; Calandra JC
Toxicol Appl Pharmacol; 1976 Oct; 38(1):79-84. PubMed ID: 185752
[No Abstract] [Full Text] [Related]
24. Changes are recommended in use of nelfinavir.
Wilcox RD
HIV Clin; 2008; 20(1):1, 4. PubMed ID: 18578034
[No Abstract] [Full Text] [Related]
25. The mutability of the minute loci of Drosophila melanogaster with ethyl methanesulfonate.
Huang SL; Baker BS
Mutat Res; 1976 Mar; 34(3):407-14. PubMed ID: 177864
[TBL] [Abstract][Full Text] [Related]
26. Dominant lethal mutations induced by MMS and mitomycin C in the fish Oryzias latipes.
Shimada A; Egami N
Mutat Res; 1984 Feb; 125(2):221-7. PubMed ID: 6422282
[TBL] [Abstract][Full Text] [Related]
27. Incidence of spontaneous post-implantation deaths in CFT-Swiss mice: its suitability to assess dominant lethal mutations.
Muralidhara ; Narasimhamurthy K
Lab Anim; 1996 Apr; 30(2):138-42. PubMed ID: 8783175
[TBL] [Abstract][Full Text] [Related]
28. Assessment of mutagenic damage following ethyl methanesulfonate mutagenesis in the axolotl (Ambystoma mexicanum).
Armstrong JB; Fletcher WS
J Exp Zool; 1983 Jun; 226(3):333-40. PubMed ID: 6886657
[TBL] [Abstract][Full Text] [Related]
29. [Assessment of the mutagenic hazards of benzene and its derivatives].
Fel'dt EG
Gig Sanit; 1985 Jul; (7):21-3. PubMed ID: 4043745
[No Abstract] [Full Text] [Related]
30. [Structure-activity relationships in experimental neuro-oncology (author's transl)].
Schreiber D; Mendel J; Heiderstädt R
Arch Geschwulstforsch; 1981; 51(7):597-603. PubMed ID: 7337542
[TBL] [Abstract][Full Text] [Related]
31. Comparison of cancer slope factors using different statistical approaches.
Subramaniam RP; White P; Cogliano VJ
Risk Anal; 2006 Jun; 26(3):825-30. PubMed ID: 16834636
[TBL] [Abstract][Full Text] [Related]
32. Proceedings: A correlated study of MMS mutagenicity with the dominant lethal test in 8 laboratories, sponsored by the Bundesministerium für Forschung und Technologie. Collaborative study of MMS mutagenicity with the dominant lethal assay in mice.
Ehling UH; Frohbert H; Schulze-Schencking M; Lang R; Lorke D; Machemer L; Matter BE; Müller D; Röhrborn G; Buselmaier W; Roll R
Mutat Res; 1975 Aug; 29(2):261. PubMed ID: 171566
[No Abstract] [Full Text] [Related]
33. Analysis of in vivo mutation data can inform cancer risk assessment.
Moore MM; Heflich RH; Haber LT; Allen BC; Shipp AM; Kodell RL
Regul Toxicol Pharmacol; 2008 Jul; 51(2):151-61. PubMed ID: 18321622
[TBL] [Abstract][Full Text] [Related]
34. A review of the genetic effects of ethyl methanesulfonate.
Sega GA
Mutat Res; 1984; 134(2-3):113-42. PubMed ID: 6390190
[TBL] [Abstract][Full Text] [Related]
35. [Mutagenic hazard of the parenteral body uptake of ethylene oxide in mammals].
Liarskiĭ PP; Iurchenko VV; Zhurkov VS; Gleĭberman SE
Gig Sanit; 1983 Jan; (1):23-6. PubMed ID: 6826062
[No Abstract] [Full Text] [Related]
36. Evidence-based dose-response assessment for thyroid tumorigenesis from acrylamide.
Dourson M; Hertzberg R; Allen B; Haber L; Parker A; Kroner O; Maier A; Kohrman M
Regul Toxicol Pharmacol; 2008 Dec; 52(3):264-89. PubMed ID: 18775759
[TBL] [Abstract][Full Text] [Related]
37. Quantitative assessment of cumulative carcinogenic risk for multiple genotoxic impurities in a new drug substance.
Bercu JP; Hoffman WP; Lee C; Ness DK
Regul Toxicol Pharmacol; 2008 Aug; 51(3):270-7. PubMed ID: 18550240
[TBL] [Abstract][Full Text] [Related]
38. Vanillin as a modulator agent in SMART test: inhibition in the steps that precede N-methyl-N-nitrosourea-, N-ethyl-N-nitrosourea-, ethylmethanesulphonate- and bleomycin-genotoxicity.
Sinigaglia M; Lehmann M; Baumgardt P; do Amaral VS; Dihl RR; Reguly ML; de Andrade HH
Mutat Res; 2006 Sep; 607(2):225-30. PubMed ID: 16777474
[TBL] [Abstract][Full Text] [Related]
39. Application of the threshold of toxicological concern approach to ingredients in personal and household care products.
Blackburn K; Stickney JA; Carlson-Lynch HL; McGinnis PM; Chappell L; Felter SP
Regul Toxicol Pharmacol; 2005 Dec; 43(3):249-59. PubMed ID: 16213074
[TBL] [Abstract][Full Text] [Related]
40. A benchmark dose analysis for sodium monofluoroacetate (1080) using dichotomous toxicity data.
Foronda NM; Fowles J; Smith N; Taylor M; Temple W
Regul Toxicol Pharmacol; 2007 Feb; 47(1):84-9. PubMed ID: 16965845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
